Prevalence of Vitamin D [25(OH)D] Deficiency and Effects of Supplementation With Ergocalciferol (Vitamin D2) in Stage 5 Chronic Kidney Disease Patients
Debra Blair, Laura Byham-Gray, Emily Lewis, Susan McCaffrey
Journal of Renal Nutrition
July 2008 (Vol. 18, Issue 4, Pages 375-382) Abstract |
Full Text |
Full-Text PDF (185 KB)
In the July 2008 issue of Journal of Renal Nutrition (Vol. 17, No. 4), in Prevalence of Vitamin D [25(OH)D] Deficiency and Effects of Supplementation With Ergocalciferol (Vitamin D2) in Stage 5 Chronic Kidney Disease Patients, by Debra Blair, MPH, RD, CSR, Laura Byham-Gray, PhD, RD, Emily Lewis, MS, RD, and Susan McCaffrey, MS, RD, pages 375–382, the correct reference was omitted on page 376 in the last paragraph in the sentence “With approximately 75% of circulating vitamin D [25(OH)D] used by the cells for “nonbone” purposes,3,12,19 adequate serum levels of this required substrate may improve health outcomes for people with CKD.” The correct reference is as follows: